# Parnaparin vs Aspirin in the Treatment of Retinal Vein Occlusion

> **NCT00732927** · PHASE3 · TERMINATED · sponsor: **Università degli Studi dell'Insubria** · enrollment: 67 (actual)

## Conditions studied

- Retinal Vein Occlusion

## Interventions

- **DRUG:** parnaparin
- **DRUG:** aspirin

## Key facts

- **NCT ID:** NCT00732927
- **Lead sponsor:** Università degli Studi dell'Insubria
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-07
- **Primary completion:** 2006-07
- **Final completion:** 2007-09
- **Target enrollment:** 67 (ACTUAL)
- **Why stopped:** slow recruitment rate
- **Last updated:** 2008-08-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00732927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00732927, "Parnaparin vs Aspirin in the Treatment of Retinal Vein Occlusion". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00732927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*